Cargando…
Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)
The uremic syndrome, which is the clinical expression of chronic kidney disease (CKD), is a complex amalgam of accelerated aging and organ dysfunctions, whereby cardio-vascular disease plays a capital role. In this narrative review, we offer a summary of the current conservative (medical) treatment...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024824/ https://www.ncbi.nlm.nih.gov/pubmed/29895722 http://dx.doi.org/10.3390/toxins10060237 |
_version_ | 1783336141737426944 |
---|---|
author | Vanholder, Raymond Van Laecke, Steven Glorieux, Griet Verbeke, Francis Castillo-Rodriguez, Esmeralda Ortiz, Alberto |
author_facet | Vanholder, Raymond Van Laecke, Steven Glorieux, Griet Verbeke, Francis Castillo-Rodriguez, Esmeralda Ortiz, Alberto |
author_sort | Vanholder, Raymond |
collection | PubMed |
description | The uremic syndrome, which is the clinical expression of chronic kidney disease (CKD), is a complex amalgam of accelerated aging and organ dysfunctions, whereby cardio-vascular disease plays a capital role. In this narrative review, we offer a summary of the current conservative (medical) treatment options for cardio-vascular and overall morbidity and mortality risk in CKD. Since the progression of CKD is also associated with a higher cardio-vascular risk, we summarize the interventions that may prevent the progression of CKD as well. We pay attention to established therapies, as well as to novel promising options. Approaches that have been considered are not limited to pharmacological approaches but take into account lifestyle measures and diet as well. We took as many randomized controlled hard endpoint outcome trials as possible into account, although observational studies and post hoc analyses were included where appropriate. We also considered health economic aspects. Based on this information, we constructed comprehensive tables summarizing the available therapeutic options and the number and kind of studies (controlled or not, contradictory outcomes or not) with regard to each approach. Our review underscores the scarcity of well-designed large controlled trials in CKD. Nevertheless, based on the controlled and observational data, a therapeutic algorithm can be developed for this complex and multifactorial condition. It is likely that interventions should be aimed at targeting several modifiable factors simultaneously. |
format | Online Article Text |
id | pubmed-6024824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60248242018-07-09 Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD) Vanholder, Raymond Van Laecke, Steven Glorieux, Griet Verbeke, Francis Castillo-Rodriguez, Esmeralda Ortiz, Alberto Toxins (Basel) Review The uremic syndrome, which is the clinical expression of chronic kidney disease (CKD), is a complex amalgam of accelerated aging and organ dysfunctions, whereby cardio-vascular disease plays a capital role. In this narrative review, we offer a summary of the current conservative (medical) treatment options for cardio-vascular and overall morbidity and mortality risk in CKD. Since the progression of CKD is also associated with a higher cardio-vascular risk, we summarize the interventions that may prevent the progression of CKD as well. We pay attention to established therapies, as well as to novel promising options. Approaches that have been considered are not limited to pharmacological approaches but take into account lifestyle measures and diet as well. We took as many randomized controlled hard endpoint outcome trials as possible into account, although observational studies and post hoc analyses were included where appropriate. We also considered health economic aspects. Based on this information, we constructed comprehensive tables summarizing the available therapeutic options and the number and kind of studies (controlled or not, contradictory outcomes or not) with regard to each approach. Our review underscores the scarcity of well-designed large controlled trials in CKD. Nevertheless, based on the controlled and observational data, a therapeutic algorithm can be developed for this complex and multifactorial condition. It is likely that interventions should be aimed at targeting several modifiable factors simultaneously. MDPI 2018-06-12 /pmc/articles/PMC6024824/ /pubmed/29895722 http://dx.doi.org/10.3390/toxins10060237 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Vanholder, Raymond Van Laecke, Steven Glorieux, Griet Verbeke, Francis Castillo-Rodriguez, Esmeralda Ortiz, Alberto Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD) |
title | Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD) |
title_full | Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD) |
title_fullStr | Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD) |
title_full_unstemmed | Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD) |
title_short | Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD) |
title_sort | deleting death and dialysis: conservative care of cardio-vascular risk and kidney function loss in chronic kidney disease (ckd) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024824/ https://www.ncbi.nlm.nih.gov/pubmed/29895722 http://dx.doi.org/10.3390/toxins10060237 |
work_keys_str_mv | AT vanholderraymond deletingdeathanddialysisconservativecareofcardiovascularriskandkidneyfunctionlossinchronickidneydiseaseckd AT vanlaeckesteven deletingdeathanddialysisconservativecareofcardiovascularriskandkidneyfunctionlossinchronickidneydiseaseckd AT glorieuxgriet deletingdeathanddialysisconservativecareofcardiovascularriskandkidneyfunctionlossinchronickidneydiseaseckd AT verbekefrancis deletingdeathanddialysisconservativecareofcardiovascularriskandkidneyfunctionlossinchronickidneydiseaseckd AT castillorodriguezesmeralda deletingdeathanddialysisconservativecareofcardiovascularriskandkidneyfunctionlossinchronickidneydiseaseckd AT ortizalberto deletingdeathanddialysisconservativecareofcardiovascularriskandkidneyfunctionlossinchronickidneydiseaseckd |